CME

CME’s moat is built on network effects in listed derivatives, clearing, and benchmark contracts across rates, equity index, FX and commodities, reinforced by high switching costs and the risk-management infrastructure clients rely on. Activity remains strong: April 2026 average daily volume was 25.9 million contracts, supporting a resilient transaction-fee engine when volatility and rate uncertainty persist. Recent product cadence (e.g., new crypto futures and expanded equity index dividend products) helps defend share and keeps CME relevant as markets evolve.

Financially, Q1 2026 showed operating leverage: revenue rose to about $1.9B (+14% YoY) with adjusted operating income around $1.37B and adjusted diluted EPS of $3.36 (+20% YoY), alongside record market data revenue of $224M. That mix matters because market data is typically stickier than trading and can smooth cycles, though trading still drives the bulk of earnings power. Valuation looks full but not extreme for quality: trailing P/E is roughly mid‑20s, and the stock’s low beta suggests investors already treat it as a defensive compounder.

Over the next 12 months, the base case is steady earnings supported by elevated rate/FX volatility and continued electronification, with incremental upside if market data and new products scale faster than expected. Key catalysts are sustained high volumes (especially rates and equity index), ongoing market data growth, and any capital return actions that lift total yield. Key risks are a prolonged low-volatility regime that compresses volumes, regulatory/margin changes that reduce trading intensity, and competitive pressure in certain contracts or alternative venues.

Recommendation: HOLD. CME is a high-quality, highly profitable exchange with strong near-term operating momentum, but the current mid‑20s earnings multiple leaves less room for error if volumes normalize.